Neutrophil granulocyte derived MMP-9 is a VEGF independent functional component of the angiogenic switch in pancreatic ductal adenocarcinoma

Angiogenesis

Volumn 14, Issue 3, 2011, Pages 235-243

  Bausch, Dirk ^a   Pausch, Thomas ^b   Krauss, Tobias ^c   Hopt, Ulrich Theodor ^a   Fernandez Del Castillo, Carlos ^d   Warshaw, Andrew L ^d   Thayer, Sarah P ^d   Keck, Tobias ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c UNIVERSITY OF FREIBURG   (Germany)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

MMP 9; Neutrophil granulocyte; Pancreatic cancer; VEGF

Indexed keywords

BEVACIZUMAB; DOXYCYCLINE; GELATINASE B; VASCULOTROPIN;

ADENOCARCINOMA; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; ARTICLE; BLOOD VESSEL PARAMETERS; CANCER COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DRUG EFFICACY; DRUG TARGETING; ENZYME INHIBITION; GROWTH INHIBITION; HUMAN; HUMAN CELL; IN VITRO STUDY; MONOTHERAPY; MOUSE; NEUTROPHIL; NONHUMAN; PANCREAS CARCINOMA; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; TUMOR VASCULARIZATION; TUMOR XENOGRAFT; VASCULAR DENSITY;

ANGIOGENESIS INHIBITORS; ANIMALS; ANTI-BACTERIAL AGENTS; ANTIBODIES, MONOCLONAL, HUMANIZED; CARCINOMA, PANCREATIC DUCTAL; CELL LINE, TUMOR; DOXYCYCLINE; FEMALE; HUMANS; MATRIX METALLOPROTEINASE 9; MICE; MICE, NUDE; NEOVASCULARIZATION, PATHOLOGIC; NEUTROPHILS; PANCREATIC NEOPLASMS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 80052719819     PISSN: 09696970     EISSN: 15737209     Source Type: Journal    
DOI: 10.1007/s10456-011-9207-3     Document Type: Article

References (42)

1. J Folkman 1971 Tumor angiogenesis: therapeutic implications N Engl J Med 285 21 1182 1186 4938153 10.1056/NEJM197111182852108 1:STN:280: DyaE38%2FgvVCqsQ%3D%3D
2. D Hanahan J Folkman 1996 Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis Cell 86 3 353 364 8756718 10.1016/S0092-8674(00)80108-7 1:CAS:528:DyaK28XltVSks7s%3D (Pubitemid 26272076)
3. N Ferrara 2002 VEGF and the quest for tumour angiogenesis factors Nat Rev Cancer 2 10 795 803 12360282 10.1038/nrc909 1:CAS:528:DC%2BD38XnsVGrtbk%3D (Pubitemid 37328914)
4. JA Nagy E Vasile D Feng C Sundberg LF Brown EJ Manseau AM Dvorak HF Dvorak 2002 VEGF-A induces angiogenesis, arteriogenesis, lymphangiogenesis, and vascular malformations Cold Spring Harb Symp Quant Biol 67 227 237 12858545 10.1101/sqb.2002.67.227 1:CAS:528:DC%2BD3sXltlGgs7g%3D (Pubitemid 36775516)
5. DW Leung G Cachianes WJ Kuang DV Goeddel N Ferrara 1989 Vascular endothelial growth factor is a secreted angiogenic mitogen Science 246 4935 1306 1309 2479986 10.1126/science.2479986 1:CAS:528:DyaK3cXls1GltLo%3D (Pubitemid 20066716)
6. WG Roberts GE Palade 1995 Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor J Cell Sci 108 Pt 6 2369 2379 7673356 1:CAS:528:DyaK2MXmsFOnsrs%3D
7. DR Senger SJ Galli AM Dvorak CA Perruzzi VS Harvey HF Dvorak 1983 Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid Science 219 4587 983 985 6823562 10.1126/science.6823562 1:STN:280:DyaL3s7hvF2mtw%3D%3D
8. R Kalluri 2003 Basement membranes: structure, assembly and role in tumour angiogenesis Nat Rev Cancer 3 6 422 433 12778132 10.1038/nrc1094 1:CAS:528:DC%2BD3sXktFOnsbw%3D (Pubitemid 37328846)
9. G Bergers R Brekken G McMahon TH Vu T Itoh K Tamaki K Tanzawa P Thorpe S Itohara Z Werb D Hanahan 2000 Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis Nat Cell Biol 2 10 737 744 11025665 10.1038/35036374 1:CAS:528:DC%2BD3cXnsVyntLk%3D
10. H Nozawa C Chiu D Hanahan 2006 Infiltrating neutrophils mediate the initial angiogenic switch in a mouse model of multistage carcinogenesis Proc Natl Acad Sci USA 103 33 12493 12498 16891410 10.1073/pnas.0601807103 1:CAS:528:DC%2BD28Xos1OjurY%3D (Pubitemid 44267286)
11. VC Ardi TA Kupriyanova EI Deryugina JP Quigley 2007 Human neutrophils uniquely release TIMP-free MMP-9 to provide a potent catalytic stimulator of angiogenesis Proc Natl Acad Sci USA 104 51 20262 20267 10.1073/pnas.0706438104 18077379 10.1073/pnas.0706438104 1:CAS:528:DC%2BD1cXjslehtA%3D%3D
12. G Hashimoto I Inoki Y Fujii T Aoki E Ikeda Y Okada 2002 Matrix metalloproteinases cleave connective tissue growth factor and reactivate angiogenic activity of vascular endothelial growth factor 165 J Biol Chem 277 39 36288 36295 12114504 10.1074/jbc.M201674200 1:CAS:528:DC%2BD38XnsVCjtrY%3D
13. LJ Hawinkels K Zuidwijk HW Verspaget ES de Jonge-Muller W van Duijn V Ferreira RD Fontijn G David DW Hommes CB Lamers CF Sier 2008 VEGF release by MMP-9 mediated heparan sulphate cleavage induces colorectal cancer angiogenesis Eur J Cancer 44 13 1904 1913 10.1016/j.ejca.2008.06.031 18691882 10.1016/j.ejca.2008.06.031 1:CAS:528:DC%2BD1cXhtVamt7vN
14. GO Ahn JM Brown 2008 Matrix metalloproteinase-9 is required for tumor vasculogenesis but not for angiogenesis: role of bone marrow-derived myelomonocytic cells Cancer Cell 13 3 193 205 10.1016/j.ccr.2007.11.032 18328424 10.1016/j.ccr.2007.11.032 1:CAS:528:DC%2BD1cXjsVKgsrc%3D (Pubitemid 351318369)
15. T Nakamura T Kuwai JS Kim D Fan SJ Kim IJ Fidler 2007 Stromal metalloproteinase-9 is essential to angiogenesis and progressive growth of orthotopic human pancreatic cancer in parabiont nude mice Neoplasia 9 11 979 986 18030366 10.1593/neo.07742 1:CAS:528:DC%2BD2sXhtl2rtrrI (Pubitemid 350086443)
16. J Condeelis JW Pollard 2006 Macrophages: obligate partners for tumor cell migration, invasion, and metastasis Cell 124 2 263 266 10.1016/j.cell.2006.01. 007 16439202 10.1016/j.cell.2006.01.007 1:CAS:528:DC%2BD28Xht1KktLo%3D (Pubitemid 43121975)
17. S Huang M Van Arsdall S Tedjarati M McCarty W Wu R Langley IJ Fidler 2002 Contributions of stromal metalloproteinase-9 to angiogenesis and growth of human ovarian carcinoma in mice J Natl Cancer Inst 94 15 1134 1142 12165638 1:CAS:528:DC%2BD38XmslOhu7c%3D (Pubitemid 34919050)
18. LM Coussens CL Tinkle D Hanahan Z Werb 2000 MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis Cell 103 3 481 490 11081634 10.1016/S0092-8674(00)00139-2 1:CAS:528:DC%2BD3cXnvF2ksLg%3D
19. S Pandol M Edderkaoui I Gukovsky A Lugea A Gukovskaya 2009 Desmoplasia of pancreatic ductal adenocarcinoma Clin Gastroenterol Hepatol 7 11 Suppl S44 S47 19896098 10.1016/j.cgh.2009.07.039 1:CAS:528:DC%2BC3cXlsFOjtw%3D%3D
20. CL Roland SP Dineen JE Toombs JG Carbon CW Smith RA Brekken CC Barnett Jr 2010 Tumor-derived intercellular adhesion molecule-1 mediates tumor-associated leukocyte infiltration in orthotopic pancreatic xenografts Exp Biol Med(Maywood) 235 2 263 270 10.1258/ebm.2009.009215 1:CAS:528:DC%2BC3cXpsFejtbs%3D
21. M Bloomston EE Zervos AS Rosemurgy 2nd 2002 Matrix metalloproteinases and their role in pancreatic cancer: a review of preclinical studies and clinical trials Ann Surg Oncol 9 7 668 674 12167581 10.1007/BF02574483 (Pubitemid 34857984)
22. Hotz HG, Hines OJ, Hotz B, Foitzik T, Buhr HJ, Reber HA (2003) Evaluation of vascular endothelial growth factor blockade and matrix metalloproteinase inhibition as a combination therapy for experimental human pancreatic cancer. J Gastrointest Surg 7 (2): 220-227; discussion 227-228. doi: S1091255X02001579
23. SR Bramhall J Schulz J Nemunaitis PD Brown M Baillet JA Buckels 2002 A double-blind placebo-controlled, randomised study comparing gemcitabine and marimastat with gemcitabine and placebo as first line therapy in patients with advanced pancreatic cancer Br J Cancer 87 2 161 167 10.1038/sj.bjc.6600446 12107836 10.1038/sj.bjc.6600446 1:CAS:528:DC%2BD38XltFeksLw%3D
24. JD Evans A Stark CD Johnson F Daniel J Carmichael J Buckels CW Imrie P Brown JP Neoptolemos 2001 A phase II trial of marimastat in advanced pancreatic cancer Br J Cancer 85 12 1865 1870 10.1054/bjoc.2001.2168 11747327 10.1054/bjoc.2001.2168 1:CAS:528:DC%2BD38XhsVWnuro%3D (Pubitemid 34775322)
25. SR Bramhall A Rosemurgy PD Brown C Bowry JA Buckels 2001 Marimastat as first-line therapy for patients with unresectable pancreatic cancer: a randomized trial J Clin Oncol 19 15 3447 3455 11481349 1:CAS:528: DC%2BD3MXmtlGhuro%3D (Pubitemid 32730080)
26. E Van Cutsem WL Vervenne J Bennouna Y Humblet S Gill JL Van Laethem C Verslype W Scheithauer A Shang J Cosaert MJ Moore 2009 Phase III trial of bevacizumab in combination with gemcitabine and erlotinib in patients with metastatic pancreatic cancer J Clin Oncol 27 13 2231 2237 19307500 10.1200/JCO.2008.20.0238
27. AH Ko E Dito B Schillinger AP Venook Z Xu EK Bergsland D Wong J Scott J Hwang MA Tempero 2008 A phase II study evaluating bevacizumab in combination with fixed-dose rate gemcitabine and low-dose cisplatin for metastatic pancreatic cancer: is an anti-VEGF strategy still applicable? Invest New Drugs 26 5 463 471 18379729 10.1007/s10637-008-9127-2 1:CAS:528:DC%2BD1cXhtVSku7fI
28. HL Kindler G Friberg DA Singh G Locker S Nattam M Kozloff DA Taber T Karrison A Dachman WM Stadler EE Vokes 2005 Phase II trial of bevacizumab plus gemcitabine in patients with advanced pancreatic cancer J Clin Oncol 23 31 8033 8040 16258101 10.1200/JCO.2005.01.9661 1:CAS:528:DC%2BD2MXht1CqsL%2FE (Pubitemid 46657405)
29. LM Golub HM Lee ME Ryan WV Giannobile J Payne T Sorsa 1998 Tetracyclines inhibit connective tissue breakdown by multiple non-antimicrobial mechanisms Adv Dent Res 12 2 12 26 9972117 10.1177/08959374980120010501 1:STN:280: DyaK1M7jvVSltg%3D%3D
30. R Hanemaaijer H Visser P Koolwijk T Sorsa T Salo LM Golub VW van Hinsbergh 1998 Inhibition of MMP synthesis by doxycycline and chemically modified tetracyclines (CMTs) in human endothelial cells Adv Dent Res 12 2 114 118 9972133 10.1177/08959374980120010301 1:STN:280:DyaK1M7jvVSrsg%3D%3D
31. EA Jaffe RL Nachman CG Becker CR Minick 1973 Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria J Clin Invest 52 11 2745 2756 4355998 10.1172/JCI107470 1:STN:280:DyaE2c%2FitFKgug%3D%3D
32. A Boyum 1968 Separation of leukocytes from blood and bone marrow. Introduction Scand J Clin Lab Invest Suppl 97 7 5707208 1:STN:280: DyaF1M7gtFKrtQ%3D%3D
33. T Korff HG Augustin 1998 Integration of endothelial cells in multicellular spheroids prevents apoptosis and induces differentiation J Cell Biol 143 5 1341 1352 9832561 10.1083/jcb.143.5.1341 1:CAS:528:DyaK1cXnvVKkurc%3D (Pubitemid 28559834)
34. T Korff HG Augustin 1999 Tensional forces in fibrillar extracellular matrices control directional capillary sprouting J Cell Sci 112 Pt 19 3249 3258 10504330 1:CAS:528:DyaK1MXntFOjurY%3D (Pubitemid 29507205)
35. H Nagase R Visse G Murphy 2006 Structure and function of matrix metalloproteinases and TIMPs Cardiovasc Res 69 3 562 573 16405877 10.1016/j.cardiores.2005.12.002 1:CAS:528:DC%2BD28XotVKitg%3D%3D (Pubitemid 43139720)
36. MD Sternlicht Z Werb 2001 How matrix metalloproteinases regulate cell behavior Annu Rev Cell Dev Biol 17 463 516 11687497 10.1146/annurev.cellbio.17. 1.463 1:CAS:528:DC%2BD3MXos1Omsbs%3D (Pubitemid 33096184)
37. RT Aimes JP Quigley 1995 Matrix metalloproteinase-2 is an interstitial collagenase. Inhibitor-free enzyme catalyzes the cleavage of collagen fibrils and soluble native type I collagen generating the specific 3/4- and 1/4-length fragments J Biol Chem 270 11 5872 5876 7890717 10.1074/jbc.270.11.5872 1:CAS:528:DyaK2MXksVCntrk%3D
38. ML Patterson SJ Atkinson V Knauper G Murphy 2001 Specific collagenolysis by gelatinase A, MMP-2, is determined by the hemopexin domain and not the fibronectin-like domain FEBS Lett 503 2-3 158 162 11513874 10.1016/S0014- 5793(01)02723-5 1:CAS:528:DC%2BD3MXmtFWit7w%3D (Pubitemid 32763197)
39. T Akahane M Akahane A Shah CM Connor UP Thorgeirsson 2004 TIMP-1 inhibits microvascular endothelial cell migration by MMP-dependent and MMP-independent mechanisms Exp Cell Res 301 2 158 167 10.1016/j.yexcr.2004.08.002 15530852 10.1016/j.yexcr.2004.08.002 1:CAS:528:DC%2BD2cXpsVOksLg%3D (Pubitemid 39504969)
40. A Dufour NS Sampson S Zucker J Cao 2008 Role of the hemopexin domain of matrix metalloproteinases in cell migration J Cell Physiol 217 3 643 651 10.1002/jcp.21535 18636552 10.1002/jcp.21535 1:CAS:528:DC%2BD1cXhtlOqt73J
41. M Paez-Ribes E Allen J Hudock T Takeda H Okuyama F Vinals M Inoue G Bergers D Hanahan O Casanovas 2009 Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis Cancer Cell 15 3 220 231 19249680 10.1016/j.ccr.2009.01.027 1:CAS:528: DC%2BD1MXltFSmtbY%3D
42. JM Ebos CR Lee W Cruz-Munoz GA Bjarnason JG Christensen RS Kerbel 2009 Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis Cancer Cell 15 3 232 239 19249681 10.1016/j.ccr.2009.01.021 1:CAS:528:DC%2BD1MXltFSmtbc%3D